For the purposes of OAR 836-200-0600 to 836-200-0670 the following definitions apply, unless the context requires otherwise:

1. (1) The “department” means the Oregon Department of Consumer and Business Services.
2. (2) “Pharmaceutical product” means a medication approved for human use by the federal Food and Drug Administration that may be legally dispensed only with a valid prescription from a health care provider.
3. (3) “Pharmaceutical representative” means a person that markets or promotes pharmaceutical products to health care providers.
4. (4) “License” means a license issued to a pharmaceutical representative by the department pursuant to OAR 836-200-0600 to 836-200-0670.
5. (5) “Licensee” means a person that holds a valid and unexpired license issued under this section.
6. (6) “Calendar year” means each successive period of 12 calendar months commencing on January 1 and ending on December 31.

7. (7) “Material change in a licensee’s business operations” means any change in the following information:

   1. (a) A change in the business activity in which the licensee engages;
   2. (b) Termination for cause from any employer or company that the licensee represents;
   3. (c) Any complaints made to the licensee, the licensee’s employer, or a company that the licensee represents regarding the licensee’s activities conducted under a license issued under these rules.
8. (8) “Monetary value,” for the purposes of describing the value of drug samples for reports made pursuant to OAR 836-200-0620(3)(e), means the monetary value of an equivalent volume or quantity of the prescription drug estimated using the WAC price for the most comparable NDC.
9. (9) “In writing” means through NIPR as allowed or by electronic mail.
10. (10) “Gift” means anything of economic value given to, or for the personal benefit of, a health care provider without consideration of equivalent or market value.

Statutory/Other Authority

ORS 731.244 & Or Laws 2021, ch 593

Statutes/Other Implemented

Or Laws 2021, ch 593

History

ID 2-2022, adopt filed 06/16/2022, effective 06/17/2022
ID 13-2021, temporary adopt filed 12/20/2021, effective 12/20/2021 through 06/17/2022